11/7
08:07 am
sgmo
Sangamo Therapeutics (NASDAQ:SGMO) had its "equal weight" rating reaffirmed by analysts at Barclays PLC. They now have a $1.00 price target on the stock, down previously from $5.00.
Low
Report
Sangamo Therapeutics (NASDAQ:SGMO) had its "equal weight" rating reaffirmed by analysts at Barclays PLC. They now have a $1.00 price target on the stock, down previously from $5.00.
11/7
07:23 am
sgmo
Rating for SGMO
Low
Report
Rating for SGMO
11/7
07:23 am
sgmo
Rating for SGMO
Low
Report
Rating for SGMO
11/7
04:38 am
sgmo
Sangamo downgraded to Equal Weight from Overweight at Barclays
Low
Report
Sangamo downgraded to Equal Weight from Overweight at Barclays
11/7
04:38 am
sgmo
Sangamo downgraded to Equal Weight from Overweight at Barclays
Low
Report
Sangamo downgraded to Equal Weight from Overweight at Barclays